Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas


Purpose:

This is a non-randomized, phase 1, study with the primary objective of determining the toxicities and establishing the maximum tolerated dose of ALIMTA when administered as a 10 minute infusion every 21 days with folic acid or multi-vitamin supplementation therapy in lightly or heavily pre-treated patients with locally advanced or metastatic cancer.


Criteria:

Inclusion Criteria: - Histologic or cytologic diagnosis of metastatic or locally advanced cancer - Prior chemotherapy is allowed - Adequate bone marrow, liver and kidney function Exclusion Criteria: - Prior treatment with ALIMTA - Brain metastasis - Pregnancy or breast feeding


NCT ID:

NCT00034463


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

San Antonio, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 14, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.